Toxoplasma gondii inhibits gamma interferon (IFN-γ)-and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA

Infection and Immunity

Volumn 82, Issue 2, 2014, Pages 706-719

  Rosowski, Emily E ^a   Nguyen, Quynh P ^a   Camejo, Ana ^a   Spooner, Eric ^b   Saeija, Jeroen P J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BRG1 PROTEIN; DNA; GAMMA INTERFERON; HISTONE DEACETYLASE; INTERFERON REGULATORY FACTOR 1; INTERFERON STIMULATED GENE FACTOR 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT1 PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN SECRETION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

CELL LINE; DNA; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERON-BETA; INTERFERON-GAMMA; PROTEIN BINDING; STAT1 TRANSCRIPTION FACTOR; TOXOPLASMA;

EID: 84892990795     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01291-13     Document Type: Article

References (60)

1. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795. http://dx.doi.org /10.1146/annurev.immunol.15.1.749.
2. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D. 2010. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50:1-14. http://dx.doi.org/10.1016/j.cyto.2009.11.021.
3. Hunn JP, Feng CG, Sher A, Howard JC. 2011. The immunity-related GTPases in mammals: a fast-evolving cell-autonomous resistance system against intracellular pathogens. Mammalian Genome 22:43-54. http://dx .doi.org/10.1007/s00335-010-9293-3.
4. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DCS, Soldati-Favre D, Horie K, Takeda J, Takeda K. 2012. A cluster of interferon-γ;-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37:302-313. http://dx.doi.org/10.1016/j.immuni.2012 .06.009.
5. Scharton-Kersten TM, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273. http://dx.doi.org/10.1084/jem.185.7.1261.
6. Pfefferkorn ER, Eckel M, Rebhun S. 1986. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol. Biochem. Parasitol. 20:215-224. http://dx.doi.org /10.1016/0166-6851(86)90101-5.
7. Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klümpers V, Lahme S, Wischmann E, Mausberg AK, Beer-Hammer S, Pfeffer K. 2013. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc. Natl. Acad. Sci. U. S. A. 110:294-299. http://dx .doi.org/10.1073/pnas.1205635110.
8. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A. 1996. In the absence of endogenous IFN-γ;, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.
9. Yap GS, Sher A. 1999. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma-and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189:1083-1091. http://dx.doi .org/10.1084/jem.189.7.1083.
10. Lieberman LA, Banica M, Reiner SL, Hunter CA. 2004. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J. Immunol. 172:457-463.
11. -/-mice. J. Immunol. 156:636.
12. Yap GS, Pesin M, Sher A. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:1-4.
13. Sibley LD, Khan A, Ajioka JW, Rosenthal BM. 2009. Genetic diversity of Toxoplasma gondii in animals and humans. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364:2749-2761. http://dx.doi.org/10.1098/rstb.2009.0087.
14. Platanias LC. 2005. Mechanisms of type-I-and type-II-interferonmediated signaling. Nat. Rev. Immunol. 5:375-386. http://dx.doi.org/10 .1038/nri1604.
15. Bach EA, Aguet M, Schreiber RD. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-591. http://dx.doi.org/10.1146/annurev.immunol.15.1.563.
16. Darnell JE, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421. http://dx.doi.org/10.1126/science.8197455.
17. Sadzak I, Schiff M, Gattermeier I, Glinitzer R, Sauer I, Saalmüller A, Yang E, Schaljo B, Kovarik P. 2008. Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc. Natl. Acad. Sci. U. S. A. 105:8944. http://dx.doi.org /10.1073/pnas.0801794105.
18. Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, Müller M, Decker T. 2003. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-γ;-dependent innate immunity. Immunity 19:793-802. http://dx.doi.org/10.1016/S1074-7613(03)00322-4.
19. Meyer T, Marg A, Lemke P, Wiesner B, Vinkemeier U. 2003. DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. Genes Dev. 17:1992-2005. http://dx.doi.org/10.1101 /gad.268003.
20. Koch V, Staab J, Ruppert V, Meyer T. 2012. Two glutamic acid residues in the DNA-binding domain are engaged in the release of STAT1 dimers from DNA. BMC Cell Biol. 13:22. http://dx.doi.org/10.1186/1471-2121 -13-22.
21. Begitt A, Meyer T, van Rossum M, Vinkemeier U. 2000. Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain. Proc. Natl. Acad. Sci. U. S. A. 97:10418-10423. http://dx.doi.org/10.1073/pnas.190318397.
22. Andrews RP, Ericksen MB, Cunningham CM, Daines MO, Hershey GKK. 2002. Analysis of the life cycle of Stat6: continuous cycling of Stat6 is required for IL-4 signaling. J. Biol. Chem. 277:36563-36569. http://dx .doi.org/10.1074/jbc.M200986200.
23. 2-macroglobulin gene. Genes Dev. 17:2564-2577. http://dx.doi.org/10.1101/gad.1135003.
24. Kim SK, Fouts AE, Boothroyd JC. 2007. Toxoplasma gondii dysregulates IFN-γ;-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J. Immunol. 178:51-54.
25. Lang C, Hildebrandt A, Brand F, Opitz L, Dihazi H, Lüder CGK. 2012. Impaired chromatin remodeling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ;. PLoS Pathog. 8:e1002483. http://dx.doi.org/10.1371/journal.ppat .1002483.
26. Rosowski EE, Saeij JPJ. 2012. Toxoplasma gondii clonal strains all inhibit STAT1 transcriptional activity but polymorphic effectors differentially modulate IFNγ; induced gene expression and STAT1 phosphorylation. PLoS One 7:e51448. http://dx.doi.org/10.1371/journal.pone.0051448.
27. Wang Y, Gao B, Xu W, Xiong S. 2011. BRG1 is indispensable for IFN-γ;-induced TRIM22 expression, which is dependent on the recruitment of IRF-1. Biochem. Biophys. Res. Commun. 410:549-554. http://dx .doi.org/10.1016/j.bbrc.2011.06.022.
28. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KDC, Saeij JPJ. 2011. Strain-specific activation of the NF-κB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 208:195-212. http://dx.doi.org/10.1084/jem.20100717.
29. Boyle JP, Saeij JPJ, Boothroyd JC. 2007. Toxoplasma gondii: inconsistent dissemination patterns following oral infection in mice. Exp. Parasitol. 116:302-305. http://dx.doi.org/10.1016/j.exppara.2007.01.010.
30. Ong Y-C, Reese ML, Boothroyd JC. 2010. Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. J. Biol. Chem. 285:28731-28740. http://dx.doi.org/10.1074/jbc .M110.112359.
31. Jensen KDC, Wang Y, Wojno EDT, Shastri A, Hu K, Cornel L, Boedec E, Ong Y-C, Chien Y-H, Hunter C a, Boothroyd JC, Saeij JPJ. 2011. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9:472-483. http://dx.doi .org/10.1016/j.chom.2011.04.015.
32. Kim S-K, Karasov A, Boothroyd JC. 2007. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Infect. Immun. 75:1626-1634. http://dx.doi.org/10.1128/IAI.01862-06.
33. Dunn JD, Ravindran S, Kim S-K, Boothroyd JC. 2008. The Toxoplasma gondii dense granule protein GRA7 is phosphorylated upon invasion and forms an unexpected association with the rhoptry proteins ROP2 and ROP4. Infect. Immun. 76:5853-5861. http://dx.doi.org/10.1128/IAI.01667-07.
34. Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S, Ferrari N, Anfosso L, Dell'Eva R, Noonan DM, Chieco-Bianchi L, Albini A, Amadori A. 2007. Identification of genes selectively regulated by IFNs in endothelial cells. J. Immunol. 178:1122-1135.
35. Zhao S, Fernald RD. 2005. Comprehensive algorithm for quantitative real-time polymerase chain reaction. J. Comput. Biol. 12:1047-1064. http: //dx.doi.org/10.1089/cmb.2005.12.1047.
36. -δδCT method. Methods 25: 402-408. http://dx.doi.org/10.1006/meth.2001.1262.
37. Lee T, Johnstone S, Young R. 2006. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat. Protoc. 1:729-748. http://dx.doi.org/10.1038/nprot.2006.98.
38. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, Thiessen N, Griffith OL, He A, Marra M, Snyder M, Jones S. 2007. Genome-wide profiles of STAT1DNAassociation using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 4:651-657. http://dx.doi.org/10 .1038/nmeth1068.
39. Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Farid Arenas A, Melo MB, Spooner E, Yaffe MB, Saeij JPJ. 2012. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog. 8:e1002784. http://dx.doi.org/10.1371/journal.ppat.1002784.
40. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705. http://dx.doi.org/10.1016/j.cell.2007.02.005.
41. Medzhitov R, Horng T. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9:692-703. http://dx.doi.org/10.1038 /nri2634.
42. Schneider AG, Abi Abdallah DS, Butcher BA, Denkers EY. 2013. Toxoplasma gondii triggers phosphorylation and nuclear translocation of dendritic cell STAT1 while simultaneously blocking IFN-γ;-induced STAT1 transcriptional activity. PLoS One 8:e60215. http://dx.doi.org/10.1371 /journal.pone.0060215.
43. Shuai K, Liu B. 2003. Regulation of JAK-STAT signaling in the immune system. Nat. Rev. Immunol. 3:900-911. http://dx.doi.org/10.1038/nri1226.
44. Lang C, Algner M, Beinert N, Gross U, Lüder CGK. 2006. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-γ;-induced major histocompatibility complex class II gene expression. Microbes Infect. 8:1994-2005. http://dx.doi.org/10.1016/j.micinf.2006.02.031.
45. Lüder CGK, Walter W, Beuerle B, Maeurer MJ, Gross U. 2001. Toxoplasma gondii downregulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1γ;. Eur. J. Immunol. 31:1475-1484. http://dx.doi.org/10 .1002/1521-4141(200105)31:5475::AID-IMMU14753.0.CO;2-C.
46. Blouin CM, Lamaze C. 2013. Interferon gamma receptor: the beginning of the journey. Frontiers Immunol. 4:267. http://dx.doi.org/10.3389 /fimmu.2013.00267.
47. Boothroyd JC, Dubremetz J-F. 2008. Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat. Rev. Microbiol. 6:79-88. http://dx.doi.org/10 .1038/nrmicro1800.
48. Håkansson S, Charron AJ, Sibley LD. 2001. Toxoplasma evacuoles: a twostep process of secretion and fusion forms the parasitophorous vacuole. EMBO J. 20:3132-3144. http://dx.doi.org/10.1093/emboj/20.12.3132.
49. Saeij JPJ, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. 2007. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445:324-327. http://dx.doi.org/10.1038 /nature05395.
50. Hobart M, Ramassar V, Goes N, Urmson J, Halloran P. 1997. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:4260-4269.
51. Silva NM, Rodrigues CV, Santoro MM, Reis LFL, Alvarez-Leite JI, Gazzinelli RT. 2002. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect. Immun. 70:859. http://dx.doi.org/10.1128/IAI.70.2.859-868.2002.
52. Ramsauer K, Farlik M, Zupkovitz G, Seiser C, Kroger A, Hauser H, Decker T. 2007. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ;-inducible gbp2 gene. Proc. Natl. Acad. Sci. U. S. A. 104:2849-2854. http://dx.doi.org/10 .1073/pnas.0610944104.
53. Li XL, Hassel BA. 2001. Involvement of proteasomes in gene induction by interferon and double-stranded RNA. Cytokine 14:247-252. http://dx.doi .org/10.1006/cyto.2001.0887.
54. Geng F, Wenzel S, Tansey WP. 2012. Ubiquitin and proteasomes in transcription. Annu. Rev. Biochem. 81:177-201. http://dx.doi.org/10.1146 /annurev-biochem-052110-120012.
55. Lipford J, Smith G, Chi Y, Deshaies R. 2005. A putative stimulatory role for activator turnover in gene expression. Nature 438:8-11. http://dx.doi .org/10.1038/nature04098.
56. Zimmermann S, Murray PJ, Heeg K, Dalpke AH. 2006. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-γ; signaling. J. Immunol. 176:1840-1847.
57. Fujimoto M, Naka T. 2003. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol. 24:659-666. http://dx.doi.org/10 .1016/j.it.2003.10.008.
58. Robinson CM, Hale PT, Carlin JM. 2006. NF-κB activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFNgamma and tumor necrosis factor-alpha. Cytokine 35:53-61. http://dx .doi.org/10.1016/j.cyto.2006.07.007.
59. Casado M, Díaz-Guerra M. 1997. Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and proinflammatory cytokines in fetal hepatocytes treated with cycloheximide. Biochem. J. 823:819-823.
60. Hershko DD, Robb BW, Wray CJ, Luo G-J, Hasselgren P-O. 2004. Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-κB in cultured caco-2 cells. J. Cell. Biochem. 91:951-961. http://dx.doi.org/10.1002/jcb .20014.